Neudorfer, Catharina <br/><br/>
Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  Sep 2014 
 - 4490-4495 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-3405 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2014.07.085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--diagnosis<br/>Dose-Response Relationship, Drug<br/>Early Diagnosis<br/>Humans<br/>Molecular Structure<br/>Monoamine Oxidase--metabolism<br/>Monoamine Oxidase Inhibitors--chemistry<br/>Positron-Emission Tomography<br/>Pyrazoles--chemistry<br/>Reference Standards<br/>Structure-Activity Relationship